{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T04:42:06Z","timestamp":1773117726091,"version":"3.50.1"},"reference-count":17,"publisher":"Tohoku University Medical Press","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2022]]},"DOI":"10.1620\/tjem.256.85","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T22:10:40Z","timestamp":1643321440000},"page":"85-91","source":"Crossref","is-referenced-by-count":1,"title":["Predictors of Treatment Response and Long-Term Outcomes in Young Children with Steroid-Dependent Nephrotic Syndrome Treated with High-Dose Mizoribine as First-Line Steroid-Sparing Agent"],"prefix":"10.1620","volume":"256","author":[{"given":"Shuichiro","family":"Fujinaga","sequence":"first","affiliation":[{"name":"Division of Nephrology, Saitama Children\u2019s Medical Centerl"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shota","family":"Endo","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Saitama Children\u2019s Medical Centerl"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshimasa","family":"Morishita","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Saitama Children\u2019s Medical Centerl"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Takemasa","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Saitama Children\u2019s Medical Centerl"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Onuki","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Saitama Children\u2019s Medical Centerl"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Sakuraya","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Saitama Children\u2019s Medical Centerl"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daishi","family":"Hirano","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Jikei University School of Medicinel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Aydin, M., Franke, I., Kurylowicz, L., Ganschow, R., Lentze, M., Born, M. &amp; Hagemann, R.(2019) The long-term outcome of childhood nephrotic syndrome in Germany: a cross-sectional study. <i>Clin. Exp. Nephrol<\/i>., 23, 676-688.","DOI":"10.1007\/s10157-019-01696-8"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Ehren, R., Benz, M.R., Brinkkotter, P.T., Dotsch, J., Eberl, W.R., Gellermann, J., Hoyer, P.F., Jordans, I., Kamrath, C., Kemper, M.J., Latta, K., Muller, D., Oh, J., Tonshoff, B., Weber, S., et al.(2021) Pediatric idiopathic steroid-sensitive nephrotic syndrome: diagnosis and therapy -short version of the updated German best practice guideline (S2e) - AWMF register no. 166-001, 6\/2020. <i>Pediatr. Nephrol<\/i>., 36, 2971-2985.","DOI":"10.1007\/s00467-021-05135-3"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Fujinaga, S., Endo, A., Ohtomo, Y., Ohtsuka, Y. &amp; Shimizu, T.(2013) Uncertainty in management of childhood-onset idiopathic nephrotic syndrome: is the long-term prognosis really favorable? <i>Pediatr. Nephrol<\/i>., 28, 2235-2238.","DOI":"10.1007\/s00467-013-2553-1"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Fujinaga, S., Hirano, D., Nishizaki, N., Someya, T., Ohtomo, Y., Ohtsuka, Y., Shimizu, T. &amp; Kaneko, K.(2011) Single daily high-dose mizoribine therapy for children with steroid-dependent nephrotic syndrome prior to cyclosporine administration. <i>Pediatr. Nephrol<\/i>., 26, 479-483.","DOI":"10.1007\/s00467-010-1707-7"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Fujinaga, S., Kaneko, K., Muto, T., Ohtomo, Y., Murakami, H. &amp; Yamashiro, Y.(2006) Independent risk factors for chronic cyclosporine induced nephropathy in children with nephrotic syndrome. <i>Arch. Dis. Child<\/i>., 91, 666-670.","DOI":"10.1136\/adc.2005.080960"},{"key":"6","unstructured":"Fujinaga, S., Ohtomo, Y., Hirano, D., Nishizaki, N., Someya, T., Ohtsuka, Y., Kaneko, K. &amp; Shimizu, T.(2009) Mycophenolate mofetil therapy for childhood-onset steroid dependent nephrotic syndrome after long-term cyclosporine: extended experience in a single center. <i>Clin. Nephrol<\/i>., 72, 268-273."},{"key":"7","doi-asserted-by":"crossref","unstructured":"Fujinaga, S., Ohtomo, Y., Umino, D., Takemoto, M., Shimizu, T., Yamashiro, Y. &amp; Kaneko, K.(2007) A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome. <i>Pediatr. Nephrol<\/i>., 22, 71-76.","DOI":"10.1007\/s00467-006-0294-0"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Ishikura, K., Matsumoto, S., Sako, M., Tsuruga, K., Nakanishi, K., Kamei, K., Saito, H., Fujinaga, S., Hamasaki, Y., Chikamoto, H., Ohtsuka, Y., Komatsu, Y., Ohta, T., Nagai, T., Kaito, H., et al.(2015a) Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy. <i>Clin. Exp. Nephrol<\/i>., 19, 6-33.","DOI":"10.1007\/s10157-014-1030-x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Ishikura, K., Yoshikawa, N., Nakazato, H., Sasaki, S., Nakanishi, K., Matsuyama, T., Ito, S., Hamasaki, Y., Yata, N., Ando, T., Iijima, K. &amp; Honda, M.; Japanese Study Group of Renal Disease in Children (2015b) Morbidity in children with frequently relapsing nephrosis: 10-year follow-up of a randomized controlled trial. <i>Pediatr. Nephrol<\/i>., 30, 459-468.","DOI":"10.1007\/s00467-014-2955-8"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Kondoh, T., Ikezumi, Y., Yokoi, K., Nakajima, Y., Matsumoto, Y., Kaneko, M., Hasegawa, H., Yamada, T., Kumagai, N., Ito, T. &amp; Yoshikawa, T.(2019) Assessment of factors associated with mizoribine responsiveness in children with steroid-dependent nephrotic syndrome. <i>Clin. Exp. Nephrol<\/i>., 23, 1154-1160.","DOI":"10.1007\/s10157-019-01754-1"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Mizutani, A., Fujinaga, S., Sakuraya, K., Hirano, D. &amp; Shimizu, T.(2019) Positive effects of single-daily high-dose mizoribine therapy after cyclophosphamide in young children with steroid-dependent nephrotic syndrome. <i>Clin. Exp. Nephrol<\/i>., 23, 244-250.","DOI":"10.1007\/s10157-018-1628-5"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Ravani, P., Bertelli, E., Gill, S. &amp; Ghiggeri, G.M.(2017) Clinical trials in minimal change disease. <i>Nephrol. Dial. Transplant<\/i>., 32, i7-i13.","DOI":"10.1093\/ndt\/gfw235"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Schijvens, A.M., van der Weerd, L., van Wijk, J.A.E., Bouts, A.H.M., Keijzer-Veen, M.G., Dorresteijn, E.M. &amp; Schreuder, M.F.(2021) Practice variations in the management of childhood nephrotic syndrome in the Netherlands. <i>Eur. J. Pediatr<\/i>., 180, 1885-1894.","DOI":"10.1007\/s00431-021-03958-8"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Sinha, A., Bagga, A., Banerjee, S., Mishra, K., Mehta, A., Agarwal, I., Uthup, S., Saha, A. &amp; Mishra, O.P.; Expert Group of Indian Society of Pediatric Nephrology (2021) Steroid sensitive nephrotic syndrome: revised guidelines. <i>Indian Pediatr<\/i>., 58, 461-481.","DOI":"10.1007\/s13312-021-2217-3"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Takemasa, Y. &amp; Fujinaga, S.(2021) Adult chronic kidney disease in childhood-onset nephrotic syndrome. <i>Pediatr. Int<\/i>., doi:org\/10.111\/ped.14846. [Epub ahead of print].","DOI":"10.1111\/ped.14846"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Xia, Z.K., Gao, Y.F., Rong, L.P., Dang, X.Q., Shen, Q., Jiang, X.Y., Yi, Z.W. &amp; Xu, H.(2019) Usefulness of mizoribine administration in children with frequently relapsing nephrotic syndrome, and the relationship between pharmacokinetic parameters and efficacy: a multicenter prospective cohort study in China. <i>World J. Pediatr<\/i>., 15, 262-269.","DOI":"10.1007\/s12519-019-00241-7"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Yoshioka, K., Ohashi, Y., Sakai, T., Ito, H., Yoshikawa, N., Nakamura, H., Tanizawa, T., Wada, H. &amp; Maki, S.(2000) A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome. <i>Kidney Int<\/i>., 58, 317-324.","DOI":"10.1046\/j.1523-1755.2000.00168.x"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/256\/1\/256_85\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:27:40Z","timestamp":1674606460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/256\/1\/256_85\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.256.85","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]}}}